PHARMACY PROVIDERS, PLEASE NOTE!!!

If you are unsure about the coverage of a drug product, please contact the PBM help desk at 1-800-648-0790.

Please file adjustments for claims that may have been incorrectly paid. Only those products of the manufacturers which participate in the Federal Rebate Program will be covered by the Medicaid program. Participation may be verified in Appendix C, available at http://www.lamedicaid.com/


Should you have any questions regarding any of the following messages, please contact Molina Medicaid Solutions at (800) 473-2783 or (225) 924-5040.


Update to 'ClaimCheck' Product Editing

McKesson's 'ClaimCheck' product is routinely updated by McKesson Corporation based on changes made to the resources used, such as Current Procedural Terminology (CPT) and Healthcare Common Procedure Coding System (HCPCS) coding guidelines, the Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule database, National Correct Coding Initiative (NCCI) edits, and/or provider specialty society updates. The 'ClaimCheck' product's procedure code edits are guided by these widely accepted industry standards.

The edit changes will affect claims processed beginning with the remittance advice of May 21, 2013 forward. Providers may notice some differences in claims editing that includes pre/post´┐Ż op days, incidental, mutually exclusive, rebundling, add-on and multiple surgery reductions. Providers should expect that some claims will continue to deny for the same error, but when applicable, claims may now pay or deny for a different reason.

With this update, Louisiana Medicaid (claims that process through the Molina claims processing system) also implemented the 2013 quarter one NCCI edits; however, the code pairs specific to preventive services and immunization administration have been deactivated based CMS approval. Doing so aligns with our intent and expectations that appropriate immunizations are to be given at the time of the preventive visit to avoid missed opportunities in both preventive care and immunizations.


Attention Professional Services Providers:

Effective with dates of service January 1, 2013 and forward, the following Current Procedural Terminology (CPT) Codes are now payable on the Professional Services Fee Schedule: 81265, 81267, 81380, and 81382. The next fee schedule update should reflect those changes. Providers should resubmit claims as appropriate. For questions related to this information, please contact Molina Medicaid Provider Services at (800) 473-2783 or (225) 924-5040.


Attention Professional Services Providers:

The Department will be conducting random audits to monitor billing practices relative to delivery/postpartum care. Louisiana Medicaid Fee-for-Service reimbursement policy for postpartum visits requires that providers shall not bill global Current Procedural Terminology (CPT) Codes covering the delivery and the postpartum visit until after the postpartum visit has been completed. Payments for services found to be inappropriately billed may be recouped. For questions related to this information, please contact Molina Provider Services at (800) 473-2783 or (225) 924-5040.


Attention Pharmacists and Prescribing Providers:

Pharmacy claims for somatropin for shared health plans or legacy recipients require a valid diagnosis code effective May 28, 2013. Claims submitted without an appropriate diagnosis code will deny with EOB 575. See http://www.lamedicaid.com/


Attention Billing Medicaid Recipients:

DHH is receiving many calls from Medicaid recipients stating that they are being billed by providers for Medicare/Medicaid services. The following is Medicaid policy concerning the processing and payment of Medicare Crossover claims. Providers are responsible for establishing internal billing procedures to ensure that Medicaid recipients are not being inappropriately billed for Medicare/Medicaid services. Please note that Medicaid does not necessarily pay the full Medicare deductible and co-insurance on a claim. A cost-comparison methodology has been used in the payment of Crossover claims for many years. Providers may not balance-bill recipients in these instances.

Dual eligibles are recipients who have Medicare and Medicaid coverage. Medicaid will reimburse the provider an amount up to the full amount of Medicare's statement of liability for co-insurance and deductible for Qualified Medicare Beneficiaries (QMB).

For claims in which Medicare's reimbursement exceeds the maximum allowable by Medicaid, Medicaid will "zero" pay the claim. This means that the claim will be shown in the Approved Claims section of the RA with a "$0" shown in the payment column. his claim is considered "paid in full" and the provider may not seek additional remuneration from the recipient.

Medicaid will pay up to the Medicare deductible and coinsurance on Medicare approved claims for non-Qualified Medicare Beneficiaries (non-QMB) receiving both Medicare and Medicaid, provided the procedure is covered by Medicaid. Medicaid will reimburse the provider an amount up to the full amount of Medicare's statement of liability for co-insurance and deductible as long as it does not exceed Medicaid's allowable reimbursement for the service. Medicaid will "zero' pay the claim when Medicare's reimbursement exceeds the maximum allowable by Medicaid.

If a recipient has both Medicare and Medicaid coverage, providers should file claims in the appropriate manner with the regional Medicare intermediary/carrier, making sure the recipient's Medicaid number is included on the Medicare claim form. Once the Medicare intermediary/carrier has processed/paid their percentage of the approved charges, Medicare will electronically submit a "crossover" claim to the Medicaid FI that includes the co-insurance and/or deductible.

If the "crossover" claim is denied by Medicare, the provider must submit a corrected claim to Medicare, if applicable.

If the "crossover" claim is not automatically crossed from Medicare and received by Medicaid, then the provider must submit a hard copy claim for payment of Medicaid's responsibility as appropriate.


Attention Professional Services Providers:
17 Alpha-Hydroxprogesterone Caproate (17P)

Louisiana Medicaid would like to provide clarification regarding policy and current reimbursement of 17 Alpha-Hydroxyprogesterone Caproate (17P). Providers are encouraged to obtain 17P on a proactive basis to have readily available to facilitate usage in the treatment of members at risk for preterm delivery. There is no prior authorization required for Fee-for-Service Medicaid. For complete information related to billing and reimbursement please, refer to the 2010 Policy Update under the Professional Services Program link on the Louisiana Medicaid website (www.lamedicaid.com). For those recipients in Bayou Health, providers should contact the member's respective Health Plan for information regarding prior authorization requirements.


Attention Pharmacists and Prescribing Providers

Pharmacy claims for sedative hypnotics for shared health plans or legacy recipients will be subject to maximum daily dosage limits effective June 18, 2013. Claims which exceed the maximum daily dose will deny with EOB 529. See http://www.lamedicaid.com/